On July 12, Almazov National Medical Research Centre hosted the delegation from Moscow, among the participants of the meeting were:
Vyacheslav Shulenin — Director General of Moscow Centre for Innovative Technologies in Healthcare, Yulia Antipova — Deputy Head of Moscow City Health Department, Saida Gadzhieva — Deputy Head of Moscow City Health Department, Roman Gostishchev – Deputy Director General of Moscow Centre for Innovative Technologies in Healthcare; Tatyana Krivenko — Deputy of the State Duma of the Russian Federation; Alexander Tsibin — Chief Visiting Specialist in clinical laboratory medicine, Head of the Department of Laboratory Service Management of the State Budgetary Institution “Research Institute of Healthcare Management”; Andrey Komarov — Director of the State Budgetary Healthcare Institution “Diagnostic Centre for Laboratory Research of Moscow City Health Department.”
During the joint meeting, Director General of Almazov Centre, Professor Evgeny Shlyakhto told the guests about the history and development of the Centre and its successful experience in translational research and value-based medicine.
Deputy Director General for Research Alexandra Konradi presented an overview of Almazov Centre’s value-based approach in the field of oncology that remains one of the most challenging areas. In this regard, the Centre established Competence Centres for Oncology as part of the Federal project “Cancer Prevention Program for 2020—2024.”
In December 2020, Almazov Centre launched the Reference Centre for Cancer Diagnosis. The Head of the Centre, Director of Polenov Neurosurgical Institute Konstantin Samochernykh told about the areas of its expertise and activities.
Director of Preclinical and Translational Research Centre of Almazov Centre Anastasia Kirichenko presented the Biobank facilities to the guests. The Biobank operates in accordance with GLP principles, medical and industrial practice standards and has a quality management system (QMS) that complies with ISO 9001 standards; its repository of biological samples operates in accordance with advanced international recommendations of ISBER (International Society for Biological and Environmental Repositories). Since 2019, the Biobank of Almazov Centre has been a member of the National Association of Biobanks and Biobanking Specialists.
Dr. Elena Vasichkina, Head of the Research Department of Unknown, Rare and Genetically Determined Diseases of the World-Class Research Centre for Personalized Medicine demonstrated the work of the Competence Centre for Hereditary, Rare and Understudied Diseases.
She explained how clinical expertise of multidisciplinary teams, modern laboratory and genetic diagnostic equipment as well as the implementation of experimental research facilitate successful diagnostic completion and medical care for patients with hereditary and rare diseases.
The delegation toured the Centre and visited the Institute of Molecular Biology and Genetics, Blood Transfusion Centre and Biobank. The guests highly praised the clinical facilities of Almazov Centre and expressed their hope for further cooperation.